ohsu

OHSU-led Consortium Wins $21 Million Grant to Study Alcoholism, Stress

The Lund Report
Consortium will continue studying mechanisms that link stress, anxiety, alcohol intake

March 8, 2012 -- The National Institute on Alcohol Abuse and Alcoholism has funded a five-year, $21 million Integrative Neuroscience Initiative on Alcoholism grant to support a multi-site consortium led by an Oregon Health & Science University researcher.

Oregon memorial service for former OHSU/UO leader Allan Price set for March 23 in Portland

The Lund Report

March 7, 2012 -- Family, friends and colleagues will celebrate the life of the late Allan Price, former OHSU Foundation president and OHSU senior vice president for advancement, at a public memorial at 3:30 p.m. on Friday, March 23, at the Portland Art Museum, 1219 S.W. Park Ave.

Price, who was 56, drowned Feb. 17 while vacationing with his wife in Mexico.

Price assumed his jobs at OHSU and the OHSU Foundation, OHSU's nonprofit fundraising affiliate, in 2008.

DOJ Memo Reveals Constitutional Concerns About Medical Liability Amendments

The Lund Report
It was enough to convince Sen. Betsy Johnson (D-Scappoose), who proved to be the swing vote that led to the passage of healthcare transformation

February 17, 2012—The vote of Sen. Betsy Johnson (D-Scappoose), a crucial swing vote when the Senate decided to allow the Oregon Health Authority to move ahead with creating coordinated care organizations (CCOs) and overhauling the Oregon Health Plan’s delivery system, changed at the last moment because memos from the Department of Justice and Oregon Health & Science University (OHSU) revealed serious constitutional concerns about the proposed medical liability language for Senate Bill 1580.

New Report Shows Oregon Clinical Trials Benefit State’s Health and Economy

The Lund Report
Clinical trials of new medicines target the most debilitating chronic diseases

Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a report released today shows.

Maternal Nutrition and Fetal Development Focus of OHSU’s New Research Center

The Lund Report
Dr. Kent Thornburg, whose research focuses on the developmental origins of disease, will take the helm of the Bob and Charlee Moore Institute for Nutrition and Wellness

February 1, 2012 -- Dr. Kent Thornburg, who teaches in the Division of Cardiovascular Medicine at Oregon Health & Science University and is known worldwide for his research into the developmental origins of disease – has been named interim director of the Bob and Charlee Moore Institute for Nutrition and Wellness, a new research and education center.

Dr. Charles Kilo Believes Competition Drives Up Healthcare Costs

The Lund Report
Calling himself a dyed in the woods capitalist, he suggests we focus on the social determinants of health rather than spending more on healthcare services

January 18, 2012 -- As policymakers wrestle with transforming Oregon’s healthcare system to control costs and improve quality, competition stands in the way, according to Dr. Charles Kilo, chief medical officer at Oregon Health & Science University.

Debt restructuring, Plans for Nutritional Center Take Center Stage at OHSU

The Lund Report
At its board meeting last Friday, a plan was approved to restructure its variable rate debt to a more stable structure

December 6, 2011 – Oregon Health & Science University intends to restructure approximately $210 million of its variable rate debt, and replace old auction rate debt with a more stable funding structure following Friday’s board meeting.

Chief Financial officer Lawrence Furnstahl had urged the board to take advantage of favorable conditions -- annual fees for credit will drop by two-thirds, from 1.80 percent to less than .60 percent for a three-year commitment, saving the university approximately $2 million a year.

Yale Chooses Oregon Evidence-Based Practice Center for Review of Bone Growth Product

The Lund Report
Center will analyze data on patients given controversial product as part of spinal surgeries

December 5, 2011 -- Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth.

The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.

Pages

Subscribe to ohsu